MEI Pharma’s Litecoin initiative signals growing institutional crypto adoption, potentially boosting Litecoin’s legitimacy and market presence.
The post Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50% appeared first on Crypto Briefing.
Leave a comment